A multicenter controlled trial of NP029 in patients with dialysis shunt insufficiency

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2032220478

Enrollment

130

Registered

2022-11-29

Start date

2022-07-13

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

dialysis shunt failure

Interventions

Randomization is performed for lesions with successful predilation. Subjects assigned to the test device (NP029) will apply the drug at NP029. Up to 3 NP029 balloons can be used up to a total length o

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients aged >=20 years at the time of consent, etc.

Exclusion criteria

Exclusion criteria: Patients who are judged by the investigator or subinvestigator to be unsuitable to participate in the study, etc.

Design outcomes

Primary

Measure	Time frame
Primary patency rate of target lesions up to 6 months after investigational procedure	—

Contacts

Public Contactyasuhiro shima

Nipro Corporation

shima-yasuhiro@nipro.co.jp+81-3-3868-5033

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026